Crop Subsidiary to Open Italian Retail Locations Launching its First Line of Hemp Oil Infused Products in Italy

VANCOUVER, British Columbia, August 30, 2018 /PRNewswire/ --

CROP Infrastructure Corp. (CSE: CROP) (OTCMKTS: CRXPF) ("CROP" or the "Company") announces it will launch its first line of Hemp oil infused cosmetic and therapeutic products under the brand 'URBAN JUVE', pursuant to its previously announced License Agreement with The Yield Growth Corp.'s subsidiary, Urban Juve Provisions Inc. (formerly Juve Wellness Inc.). The License Agreement gives CROP exclusive rights in Italy to the URBAN JUVE products, as well as non-exclusive distribution rights in the United States.

Furthermore, the Company in partnership with the team from Xhemplar S.R.L. CROP's cultivation and extraction joint venture partner in Italy, is scouting locations to open 2 CBD retail outlets in Northern Italy under the company's Emerald Heights brand, before the end of 2018.

The URBAN JUVE product line which will be featured prominently along with Xhemplar products, and Hempire hemp oil products at all Italy locations. Urban Juve is inspired by Ayurvedic philosophy and is created for the modern, wellness-conscious consumer. The unique formulations benefit consumers seeking natural products made with the highest quality ingredients. Urban Juve is manufacturing its first line of 12 topical products in the fall of 2018. All the products contain hemp oil procured through a patent pending hemp oil extraction process. Crop has the right to add hemp oil to the products and distribute them throughout Italy.

According to a study by Arcview Market Research and its research partner BDS Analytics, by 2027 worldwide sales of legal cannabis are forecast to reach $57 billion. During that period, spending in North America is expected to leap from $9.2 billion to $47.3 billion driven mainly be recreational use. The fastest cannabis market growth is expected to come from outside North America, especially Europe where the main growth driver will be medical applications. Medical cannabis use will be fed by $1.3 trillion estimated annual government-subsidized healthcare spending. The structure of the healthcare industry is expected to make Europe the number one medical cannabis market in the world.

"We are excited to be partnered with CROP for the European launch of the URBAN JUVE hemp oil infused product line," says Penny Green, President and CEO of Yield Growth. "CROP is a demonstrated leader in the international hemp market with affiliations to hemp production in Nevada, California, Washington, Italy and Jamaica."

CROP Infrastructure Director & CEO Michael Yorke, states: "We are pleased with the URBAN JUVE branding initiative by Yield Growth and feel it will resonate with health and lifestyle consumers. We look forward to offering the URBAN JUVE products in Italy."

About CROP Infrastructure Corp. 

CROP Infrastructure Corp. is publicly listed on the Canadian Securities Exchange and trades under the symbol "CROP" and in the U.S. under the symbol "CRXPF". CROP is primarily engaged in the business of investing, constructing, owning and leasing greenhouse projects as part of the provision of turnkey real estate solutions for lease-to-licensed cannabis producers and processors offering best-in-class operations. The Company's portfolio of assets includes cultivation properties in California, Washington State, Nevada, Italy, Jamaica and a joint venture on West Hollywood and San Bernardino dispensary applications. CROP has developed a portfolio of 16 Cannabis brands and has U.S. and Italian distribution rights to a line of over 55 topical cannabis products from The Yield Growth Corp.

Disclaimer for Forward-Looking Information 

Forward-looking statements are not based on historical facts, but rather on current expectations and projections about future events, and are therefore subject to risks and uncertainties which could cause actual results to differ materially from the future results expressed or implied by the forward-looking statements. In addition, marijuana remains a Schedule I drug under the United States Controlled Substances Act of 1970. Although Congress has prohibited the US Justice Department from spending federal funds to interfere with the implementation of state medical marijuana laws, this prohibition must be renewed each year to remain in effect. These statements generally can be identified by the use of forward-looking words such as "may", "should", "could", "intend", "estimate", "plan", "anticipate", "expect", "believe" or "continue", or the negative thereof or similar variations. Forward-looking statements in this news release include statements regarding the expected yield from The Jamaica Property; the technological effects of The Jamaica Property on production; the intention to expand its portfolio; and execute on its business plan. Such statements are qualified in their entirety by the inherent risks and uncertainties surrounding the regulatory and legal framework regarding the cannabis industry in general among all levels of government and zoning; risks associated with applicable securities laws and stock exchange rules relating to the cannabis industry; risks associated with maintaining its interests in its various assets; the ability of the Company to finance operations and execute its business plan and other factors beyond the control of the Company. Such forward-looking statements should therefore be construed in light of such factors, and the Company is not under any obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by applicable law.

Company Contact:
Michael Yorke - CEO & Director
E-mail: info@cropcorp.com
Website: www.cropcorp.com
Phone: (604)-484-4206